Vontobel Holding
GBIO

Vontobel Holding’s Generation Bio GBIO Stock Holding History

Vontobel Holding’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-35,674
Closed -$1.35M – 1129
2023
Q3 		$1.35M Hold
35,674
– – 0.01% 520
2023
Q2 		$1.96M Sell
35,674
-2,833
-7% -$130K 0.02% 446
2023
Q1 		$1.66M Buy
38,507
+11,128
+41% +$538K 0.02% 463
2022
Q4 		$1.08M Buy
+27,379
New +$1.44M 0.01% 555

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vontobel Holding's GBIO Position: Q4 2023 in Review

Vontobel Holding sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 35,674 shares — an estimated $1.35M sold.

Vontobel Holding first reported a position in GBIO in Q4 2022 and held it in 4 quarters. The position peaked at $1.96M in Q2 2023. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • Vontobel Holding reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • Vontobel Holding sold 35,674 Generation Bio shares in Q4 2023, an estimated $1.35M.
  • Vontobel Holding first reported a position in Generation Bio in Q4 2022 and held it in 4 quarters.
  • Vontobel Holding's Generation Bio position peaked at $1.96M in Q2 2023.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on Vontobel Holding's 13F filing for Q4 2023, filed 30 Jan 2024.